ASHLEY VINSON: Open Payments
NPI 1437633229 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 39 payments from 14 companies in 2025. Trend: 2023 $3,677 · 2024 $3,058 · 2025 $1,677
Long term medical supply or device loan: $1,082Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $1,082 |
| PFIZER INC. | 6 | $124 |
| ABBVIE INC. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| Stemline Therapeutics Inc. | 2 | $47 |
| SOBI, INC | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Medtronic, Inc. | 1 | $26 |
Products named: KISQALI, PADCEV, IMBRUVICA, Orserdu, Xtandi, ENHERTU, Doptelet, IBRANCE.
Industry payments across GA — which companies pay providers there.
